Testing effectiveness (Phase 2)UnknownNCT02268747
What this trial is testing
Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer
Who this might be right for
Skin Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 43